Nyxoah S.A. Actions Nom. o.N.

Sector and Industry

Healthcare, Healthcare Equipment

Performance (1Y)

80.12%

Market Cap

130.70 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-2.36 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Abbott Laboratories185.26 Bil.39.29 Bil.33.69
-53.32 %
0.00
-
Intuitive Surgical Inc171.24 Bil.8.92 Bil.71.93
+17.90 %
0.00
-
Boston Scientific Corp120.40 Bil.17.79 Bil.49.17
+49.88 %
0.00
-
Stryker Corp.114.47 Bil.22.26 Bil.41.85
+3.99 %
0.00
-
Medtronic PLC90.93 Bil.31.27 Bil.22.35
-4.61 %
0.00
-
Siemens Healthineers AG51.40 Bil.23.38 Bil.24.04
+10.40 %
0.00
-
Hoya Corp48.59 Bil.5.43 Bil.35.69
+17.33 %
0.00
-
Becton Dickinson and Co.45.46 Bil.19.79 Bil.32.18
-3.33 %
0.00
-
Edwards Lifesciences Corp42.15 Bil.5.38 Bil.47.11
-27.44 %
0.00
-
Alcon AG33.20 Bil.9.24 Bil.38.41
-7.56 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE1.372 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 11:31:23 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW1.391.332
PREV. DAY'S PRICE1.308 (07/21)
CHANGE DAY BEFORE
+0.06
4.89 %
52 WEEK HIGH / LOW8.2 (08/11)1.074 (06/09)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-1.55-1.81-2.36-1.06-0.73
DIVIDENDS PER SHARE
0.000.000.000.501.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
1.252.723.58--
PRICE - SALES RATIO
27.4059.8215.54--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A2QCWK
ISIN
BE0974358906
SYMBOL
5YI
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
NYXOAH S.A.
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Equipment
NUMBER OF SHARES
99.93 Mil.
MARKET CAPITALISATION
130.70 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-8.15 %
-2.39 %
-49.30 %
-67.01 %
-80.12 %
-80.76 %
-95.21 %
-65.85 %
HIGH1.461.782.784.258.2016.7527.654.67
LOW1.291.291.071.071.071.071.071.07

Dividende

pro Aktie

Company profile

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.